MedTrace Logo

Painless Myocardial Ischemia in Diabetic Patients.

NCT04071808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-04-20

No results posted yet for this study

Summary

This study aims to investigate the relationship between the concentrations of blood orphanin, norepinephrine and the morbidity of painless myocardial ischemia in patients with diabetes mellitus. Hopefully, the biomarker(s) in the blood of diabetic patients can be found for screening high risk patients in the diabetes sufferers to prevent the painless myocardial ischemia.

Conditions

  • Painless Myocardial Ischemia

Interventions

DIAGNOSTIC_TEST

ELISA Test

The levels of orphanin and norepinephrine in blood of diabetic patients with painless myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy were measured.

Sponsors & Collaborators

  • Second Hospital of Shanxi Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2019-12-30
Completion
2020-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04071808 on ClinicalTrials.gov